Tag Archives: ip

Enzo Biochem V. Applera Corp. – When “Words Can Hurt You”

Posted on March 19, 2015 by Warren Woessner

On March 16, 2015 (Appeal no. 2014-1321), the Fed. Cir. reversed the district court’s construction of a claim term relating to the scope of “A,” a moiety capable of direct or indirect signaling that is attached by a linker to … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , | Leave a comment

Takeaways from Chisum Patent Academy 2015 Seminar in Cincinnati

Posted on March 11, 2015 by Warren Woessner

Guest Post from Don Chisum On March 5-6, 2015 the Chisum Patent Academy held a two-day seminar at the 21C Museum Hotel in downtown Cincinnati, Ohio to discuss and debate current developments in U.S. patent law. The roundtable seminar group … Continue reading →

Posted in Conferences and Classes, Uncategorized | Tagged , , , , , , , | Leave a comment

Novartis Wins Landmark Biosimilar Approval

Posted on March 9, 2015 by Warren Woessner

Novartis Navigates The FDA-ACA Maze – Gets Approval For Generic Neuprogen. Amgen will soon find itself in a price war with Sandoz – a Novartis company – as it tries to maintain its share of the market for Neuprogen (filgraslim). … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , | Leave a comment

Universities Response to Patent “Reform” Legislation

Posted on February 27, 2015 by Warren Woessner

On February 24th, a letter sent by the Association of American Universities, signed by 145 universities, to Senators Grassley and Leahy and Representatives Goodlatte and Conyers, objected to parts of legislation such as “The Innovation Act, H.R. 9” that purports … Continue reading →

Posted in Patent Reform Legislation | Tagged , , , , , , , | 1 Comment